High-level consultative dialogue on the EU-Africa Global Health Partnership
Background
A high-level consultative dialogue on the EU-Africa Global Health Partnership (GHP), the successor of the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP2) under Horizon Europe, the EU Framework Programme of Research and Innovation, as part of the ongoing discussions and public consultation about the framework concerning the new GHP will be held on 16 March 2020, in Cape Town, South Africa. It is organised by the European Commission (EC), South African Department of Science & Innovation (DSI) and EDCTP.
During the last EU-AU High-Level Policy Dialogue on Science and Technology, held in Addis Ababa, Ethiopia, in November 2020, the senior officials called “on all European and African Union Member States to consider the questions for reflection on the future orientation of EDCTP, and proposed the convening of a consultation event”. The South African Department of Science & Technology offered to host the consultation.
The consultative dialogue will take the form of a workshop organised by the South African Department of Science & Innovation in collaboration with the EDCTP Africa Office and the Director-General Research and Innovation of the European Commission. The main objective of the one-day consultative dialogue is to explore opportunities for enhanced Africa-EU cooperation in global health research. The workshop is aimed at presenting and discussing the scope, possible modalities of the new partnership that will be the successor of EDCTP2 programme.
This meeting is by invitation only.
Speakers
Dr Barbara Kerstiëns, Head of Unit, European Commission Directorate-General Research & Innovation, E2 – ‘Combatting diseases’
Dr Michael Makanga, EDCTP Executive Director
Dr Bernard Rey, Minister Counsellor and Head of Cooperation of the Delegation of the European Union to South Africa
Dr Leonardo Simão, EDCTP High Representative for Africa
Prof. Marcel Tanner, EDCTP High Representative for Europe
Prof Jeffrey Mphahlele, Vice President for Research, South African Medical Research Council (SAMRC),
Dr Anthony Man, Global Therapeutic Area Head, Global Health Development Unit at Novartis
Prof. Collen Masimirembwa, President of the African Pharmacogenomics Consortium (APC) and founder of the African Institute of Biomedical Science and Technology (AiBST).
Prof. Francine Ntoumi, Chair and Executive Director of the Congolese Foundation for Medical Research, Republic of Congo
Resources
For more information see: